BioSpace News Archive

Solid Biosciences Inc. today announced the appointment of Kevin Tan, CFA, a seasoned industry professional, as Chief Financial Officer.

Kiniksa Pharmaceuticals, Ltd. today provided a corporate and portfolio update.

ORIC Pharmaceuticals, Inc. today provided program updates and announced upcoming key milestones.

Trinity Biotech today announced a strategic partnership with imaware Inc that combines their built-to-partner digital health platform with Trinity Biotech’s advanced reference laboratory facilities to power the Digital Health Industry with at-home and remote testing programs.

Premier Research and Centogene N.V. have announced a strategic partnership to provide end-to-end support in rare disease clinical trials.

Theralink Technologies today announced the appointment of Michael Vallone as Senior Director of Commercialization.

Lydus Medical is pleased to announce that the Vesseal™ has received FDA clearance 510(k).

Avenge Bio, Inc. (“Avenge”), an oncology-focused biotechnology company developing the LOCOcyte™ Immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, today announced dosing of the first patient in a First-in-Human Phase 1/2 clinical trial evaluating AVB-001 in relapsed refractory ovarian cancer.

NeuroDerm Ltd. today announced highly positive results from the Phase III multi-center, randomized, double-blind double-dummy (DBDD) BouNDless trial.

Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications, today announced that Dr. Jonathan Kaufman, Co-Founder, Chairman, and CEO will be presenting at Biotech Showcase™ 2023.